Nonprofit Brings NARCAN over-the-counter
A lifesaving medication that reverses opioid overdoses will soon become more accessible, thanks to an innovative nonprofit company. Harm Reduction Therapeutics has received FDA approval for RiVive, the first over-the-counter naloxone nasal spray created by a nonprofit.
Available in early 2024, RiVive aims to save lives by providing broad, low-cost access to this critical drug. Unlike big pharma, Harm Reduction Therapeutics is focused on equipping hardest-hit communities – not profits. At least 200,000 doses will be distributed free of charge where they are needed most.
This creative approach could be a game-changer in expanding access to naloxone, a medication that can mean the difference between life and death for those experiencing an opioid overdose. Harm Reduction Therapeutics exemplifies the power of nonprofits to drive real change.
Elon Musk blames Anti-Defamation League for ad sales slump, threatens lawsuit | Axios
More schools that forced American Indian children to assimilate revealed | Washington Post
Worker defrauds Massachusetts nonprofit out of $100,000 worth of Apple laptops, officials say | WCVB Boston
Podcast: Play in new window | Download
--------
NonprofitNewsfeed.com Summary of hundreds of news sources.
